Published Studies Related to Pulmicort Respules (Budesonide)
Well-designed clinical trials related to Pulmicort Respules (Budesonide)
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2008.08.22]
Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.08.07]
[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]
Budesonide for induction of remission in Crohn's disease. [2008.07.16]
Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. [2008.07]
Evidence of the in vivo esterification of budesonide in human airways. [2008.07]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. [2008.05]
Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. [2008.05]
Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers. [2008.05]
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. [2008.05]
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. [2008.05]
Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations. [2008.04]
Long-term effects of budesonide on inflammatory status in COPD. [2008.04]
The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. [2008.03]
Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]
Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. [2008]
Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects. [2008]
Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease : results of a 6-month randomized clinical trial. [2008]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]
Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. [2007.10]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.10]
Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. [2007.10]
The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease. [2007.10]
Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission. [2007.10]
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]
Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. [2007.09]
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. [2007.08]
Comparison of the efficacy and safety of ciclesonide 160 mug once daily vs. budesonide 400 mug once daily in children with asthma. [2007.08]
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. [2007.08]
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. [2007.08]
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. [2007.08]
An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers. [2007.08]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.07.10]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma. [2007.07]
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. [2007.06]
Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis. [2007.06]
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. [2007.05]
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]
Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Ciclesonide is more effective than budesonide in the treatment of persistent asthma. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. [2006.12]
Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis. [2006.10]
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial. [2006.06]
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. [2006.06]
Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. [2006.06]
Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray. [2006.05]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial. [2006.05]
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. [2006.04]
Activity of budesonide on nasal neutrophilic inflammation and obstruction in children with recurrent upper airway infections. A preliminary investigation. [2006.03]
Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. [2006.03]
Effectiveness of budesonide nebulising suspension compared to disodium cromoglycate in early childhood asthma. [2006.02]
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]
Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. [2006.02]
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis. [2006.01.15]
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. [2006.01]
The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. [2006.01]
Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. [2006]
Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. [2006]
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [2006]
Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide. [2005.12]
Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. [2005.12]
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? [2005.11]
Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study. [2005.11]
Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting. [2005.11]
Budesonide for induction of remission in Crohn's disease. [2005.10.19]
The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. [2005.10]
Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma. [2005.10]
Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. [2005.09]
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. [2005.08]
Adjustable maintenance dosing with budesonide/formoterol or budesonide: Double-blind study. [2005.07.07]
Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma. [2005.07]
The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. [2005.07]
A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. [2005.07]
Oral budesonide therapy improves quality of life in patients with collagenous colitis. [2005.07]
Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. [2005.06]
Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study. [2005.06]
Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge. [2005.06]
Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers. [2005.06]
Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. [2005.06]
Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. [2005.06]
Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. [2005.05]
Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. [2005.05]
The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. [2005.04]
|
